-
Bristol-Myers Squibb Company (BMY $44.82)
-
Johnson & Johnson (JNJ $170.59)
-
Merck & Company Inc. (MRK $79.44)
-
Pfizer Inc. (PFE $23.93)
Q: i have held this for about 5 years and it has basically done nothing despite all the promises from management for change/consolidation etc. Would you support continuing to hold or am i better switching to a better growth name. i am retired so i like a bit of income in addition to share price appreciation. i already own ABBV and MDT and do not want to add to these positions. i am better off in Merck or PFE?